Intravenous immunoglobulin for chronic residual peripheral neuropathy in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome): a multicenter, double-blind trial
Eosinophilic granulomatosis with polyangiitis (EGPA), previously called Churg–Strauss syndrome, frequently affects the peripheral nervous system. We conducted a multicenter, double-blind, three-arm treatment period, randomized, pre-post trial to assess the efficacy of intravenous immunoglobulin (IVI...
Main Authors: | Koike, Haruki, Akiyama, Kazuo, Saito, Toyokazu, Sobue, Gen |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer Berlin Heidelberg
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363522/ |
Similar Items
-
Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
by: Thiel, Jens, et al.
Published: (2013) -
Serum Biomarkers in Patients with Relapsing Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss)
by: Dejaco, Christian, et al.
Published: (2015) -
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) presenting as diffuse myositis
by: Parent, Marc-Etienne, et al.
Published: (2014) -
High-dose intravenous immunoglobulin therapy for eosinophilic granulomatosis with polyangiitis
by: Tsurikisawa, Naomi, et al.
Published: (2014) -
Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide
by: Umeda, Akira, et al.
Published: (2014)